The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorNational Cheng-Kung University Hospital
About this trial
The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are:
Does AR guided CPAP therapy increase the adherence of CPAP therapy among OSA patients? What barriers do participants have when using AR guided CPAP therapy? Researchers will compare AR guided CPAP therapy to a control (standard of care) to see if AR guided CPAP therapy works to enhance the adherence of CPAP therapy.
Participants will:
1. Take AR guided CPAP therapy or standard of care every day for 6 months 2. Visit the clinic on baseline (t0), receiving CPAP therapy at the 1st month (t1), for checkups and tests, receiving CPAP therapy at the 3rd month (t2), receiving CPAP therapy at the 6th month (t3). 3. Response their symptoms on each following time.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
(1) Diagnosed with moderate to severe obstructive sleep apnea (AHI≥15) through polysomnography (PSG).
(2) Age is equal to or greater than 20 years old or equal.
Disqualifiers
(1) individuals who have previously used positive pressure ventilators for treatment,
(2) those diagnosed with central sleep apnea,
(3) those with uncontrolled acute mental illness,
(4) terminally ill patients.
Trial design
Design model
Parallel
Treatments tested in this trial
With AR guided CPAP therapy
BehavioralParticipants will received AR training course to utilize the AR guided CPAP therapy
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: With AR guided CPAP therapyExperimental treatment 1 intervention
Group B: Standard of careNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
The adherence of CPAP therapy
Adherence refers to the patient's adherence to CPAP therapy, which means using CPAP for more than 70% of the total sleep time during the night, with a minimum duration of 4 hours. The calculation method involves dividing the number of days with CPAP use exceeding 4 hours by the total number of days and multiplying by 100 to obtain the average percentage of CPAP usage.
Time frame
From enrollment to the end of treatment at 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
National Cheng-Kung University Hospital
Lead sponsor
National Sun Yat-sen University
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: